US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Idiopathic pulmonary fibrosis – on the cusp of a revolution; how will forthcoming approvals shape the treatment and development landscapes? - Physician Views
5/27/2014 | published by: FirstWord
... pulmonary fibrosis (IPF). Positive Phase III data are expected to act as the springboard for FDA approvals of InterMune's Esbriet (pirfenidone) and Boehringer Ingelheim's nintedanib by late 2014/early 2015. Launch and uptake of these products ...  |  read more...
USD 645
Lung Disease - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... therapeutic development for Lung Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cystic Fibrosis Partnering 2009-2014
4/1/2014 | published by: Current Partnering
... deals Top cystic fibrosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Cystic Fibrosis Partnering 2009-2014 provides understanding and access to the cystic fibrosis partnering deals and agreements ...  |  read more...
USD 695
Idiopathic Pulmonary Fibrosis Partnering 2009-2014
4/1/2014 | published by: Current Partnering
... in idiopathic pulmonary fibrosis partnering deals Top idiopathic pulmonary fibrosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Idiopathic Pulmonary Fibrosis Partnering 2009-2014 provides understanding and access ...  |  read more...
USD 695
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
2014 U.S. Patient care - Respiratory system sold through Medical & surgical hospitals-Product & Services Report
4/15/2014 | published by: Barnes Reports
... annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2014 current and 2015 forecast estimates on the sales of Patient care - Respiratory system sold through Medical & ...  |  read more...
USD 199
Pulmonary Arterial Hypertension - Pipeline Review, H1 2014
4/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Pulmonary Arterial Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Pulmonary Tuberculosis - Pipeline Review, H1 2014
4/28/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Tuberculosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cough Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
Lung Cancer Treatment Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term ...  |  read more...
USD 4,000
Acute Lung Injury - Pipeline Review, H1 2014
5/21/2014 | published by: Global Markets Direct
... information on the therapeutic development for Acute Lung Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
5/26/2014 | published by: GlobalData
... Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status ...  |  read more...
USD 2,500
Market Highlights: Italy Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Italy. The research includes Italy chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Germany Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: France Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Italy Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Japan Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: US Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... the US bronchitis market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research ...  |  read more...
USD 990
Update: Chronic Obstructive Pulmonary Disease Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... Pulmonary Disease market. It covers emerging therapies for Chronic Obstructive Pulmonary Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking ...  |  read more...
USD 590
Market Highlights: Spain Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Spain. The research includes Spain chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: UK Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in UK. The research includes UK chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Germany Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Germany. The research includes Germany chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Japan Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in Japan. The research includes Japan chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Market Highlights: Europe Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... disease drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six ...  |  read more...
USD 2,800
Update: Cystic Fibrosis Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Cystic Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
1    3    5  6  7  8  9  10